452 related articles for article (PubMed ID: 8432219)
1. Lipoprotein abnormalities in well-treated type II diabetic patients.
Manzato E; Zambon A; Lapolla A; Zambon S; Braghetto L; Crepaldi G; Fedele D
Diabetes Care; 1993 Feb; 16(2):469-75. PubMed ID: 8432219
[TBL] [Abstract][Full Text] [Related]
2. Relation of abnormal composition of lipoproteins to HbA1c levels in non-insulin dependent diabetes.
Sánchez-Cabezudo M; Ródenas S; Cuesta C
Rev Esp Fisiol; 1994 Sep; 50(3):145-51. PubMed ID: 7886271
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients.
Manzato E; Zambon A; Zambon S; Nosadini R; Doria A; Marin R; Crepaldi G
Acta Diabetol; 1993; 30(1):11-6. PubMed ID: 8329725
[TBL] [Abstract][Full Text] [Related]
4. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.
al-Muhtaseb N; al-Yuosuf AR; Bajaj JS
Acta Diabetol Lat; 1991; 28(1):61-9. PubMed ID: 1862693
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein subfraction composition in non-insulin-dependent diabetes treated by diet, sulphonylurea, and insulin.
Billingham MS; Milles JJ; Bailey CJ; Hall RA
Metabolism; 1989 Sep; 38(9):850-7. PubMed ID: 2671598
[TBL] [Abstract][Full Text] [Related]
7. Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control?
Romano G; Patti L; Innelli F; Di Marino L; Annuzzi G; Iavicoli M; Coronel GA; Riccardi G; Rivellese AA
Diabetes; 1997 Oct; 46(10):1601-6. PubMed ID: 9313756
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia.
Stewart MW; Laker MF; Dyer RG; Game F; Mitcheson J; Winocour PH; Alberti KG
Arterioscler Thromb; 1993 Jul; 13(7):1046-52. PubMed ID: 8318506
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein lipids and apolipoproteins (AI, AII, B, CII, CIII) in type 1 and type 2 diabetes mellitus in young Kuwaiti women.
al-Muhtaseb N; al-Yusef AR; Bajaj JS
Diabet Med; 1991 Oct; 8(8):732-7. PubMed ID: 1838064
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein subfraction composition in non-obese newly diagnosed non-insulin dependent diabetes after treatment with diet and glibenclamide.
Billingham MS; Milles JJ; Bailey CJ; Hall RA
Diabetes Res; 1989 May; 11(1):13-20. PubMed ID: 2515931
[TBL] [Abstract][Full Text] [Related]
11. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
[TBL] [Abstract][Full Text] [Related]
12. Alterations in composition and concentration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus (NIDDM).
Elchebly M; Porokhov B; Pulcini T; Berthezène F; Ponsin G
Atherosclerosis; 1996 Jun; 123(1-2):93-101. PubMed ID: 8782840
[TBL] [Abstract][Full Text] [Related]
13. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.
Brunzell JD; Albers JJ; Chait A; Grundy SM; Groszek E; McDonald GB
J Lipid Res; 1983 Feb; 24(2):147-55. PubMed ID: 6403642
[TBL] [Abstract][Full Text] [Related]
14. The transport of vitamin E in plasma and its correlation to plasma lipoproteins in non-insulin-dependent diabetes mellitus.
Kökoğlu E; Ulakoğlu E
Diabetes Res Clin Pract; 1991 Dec; 14(3):175-81. PubMed ID: 1778110
[TBL] [Abstract][Full Text] [Related]
15. Lipoproteins and apolipoproteins in young nonobese Arab women with NIDDM treated with insulin.
Al-Muhtaseb N; Al-Yusuf AR; Abdella N; Fenech F
Diabetes Care; 1989 May; 12(5):325-31. PubMed ID: 2656141
[TBL] [Abstract][Full Text] [Related]
16. Anomalous lipoproteins in obese Zucker rats.
Blay M; Peinado-Onsurbe J; Julve J; Rodríguez V; Fernández-López JA; Remesar X; Alemany M
Diabetes Obes Metab; 2001 Aug; 3(4):259-70. PubMed ID: 11520306
[TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
[TBL] [Abstract][Full Text] [Related]
18. Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables.
Phillips NR; Havel RJ; Kane JP
Am J Epidemiol; 1982 Aug; 116(2):302-13. PubMed ID: 6810694
[TBL] [Abstract][Full Text] [Related]
19. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women.
Chiuve SE; Martin LA; Campos H; Sacks FM
J Clin Endocrinol Metab; 2004 May; 89(5):2207-13. PubMed ID: 15126543
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein compositional abnormalities in type I diabetes: effect of improved glycaemic control.
Pérez A; Caixàs A; Carreras G; Mauricio D; Pou JM; Serrat J; Gómez-Gerique J; de Leiva A
Diabetes Res Clin Pract; 1997 May; 36(2):83-90. PubMed ID: 9229192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
